跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,671 条关于
“RK-251”
全部
3,671
临床试验
2,100
药物
1,183
机构
13
资讯
375
上个月
Smart Cancer Drug RK-251 Activates Only in Cancer Cells, Offering Targeted Alternative to Chemotherapy
去年
RK-33 Eliminates Bone Metastases in Breast Cancer Models
去年
CREATE Protocol Shows Promise in Correcting RK-Induced Corneal Irregularity
去年
Dyne's DYNE-251 Shows "Unprecedented" Functional Improvements in Duchenne Muscular Dystrophy Trial
去年
Zydus Lifesciences Secures Two Strategic Partnerships for Novel 505(b)(2) Oncology Products in US Market
去年
STRATA Excimer Laser Combined with JAK Inhibitors Shows 100% Response Rate in 251-Patient Vitiligo Trial
2年前
Dyne Therapeutics' DYNE-251 Shows Promising Dystrophin Expression and Functional Improvements in Duchenne Muscular Dystrophy Trial
去年
Dyne Therapeutics Advances DMD Treatment Program Despite Price Target Adjustment
去年
Dyne Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Update
去年
Vicebio Secures $100 Million to Advance RSV and hMPV Combination Vaccine
第 1 页,共 38 页
上一页
下一页